Evidence map›Paper›PMID 31051451›Full record

ArticleIET nanobiotechnology2019

Silver nanoparticles fabricated using medicinal plant extracts show enhanced antimicrobial and selective cytotoxic propensities.

Parth Sarthi Nayak, Stuti Pradhan, Manoranjan Arakha, Dileep Kumar, Mohammed Saleem, Bibekanand Mallick, Suman Jha

Open access · greenAbstract read
In one paragraph

Article in IET nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Green Synthesis of Silver Nanoparticles withPlants (Basel, Switzerland) · 2024
    Article
  5. Therapeutic applications of nanobiotechnology.Journal of nanobiotechnology · 2023
    Review
  6. Silver Nanoparticles Phytofabricated throughAntibiotics (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Parth Sarthi NayakDepartment of Life Science, National Institute of Technology Rourkela, Odisha 769008, India.
Stuti PradhanDepartment of Life Science, National Institute of Technology Rourkela, Odisha 769008, India.
Manoranjan ArakhaDepartment of Life Science, National Institute of Technology Rourkela, Odisha 769008, India.
Dileep KumarDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Mohammed SaleemDepartment of Life Science, National Institute of Technology Rourkela, Odisha 769008, India.
Bibekanand MallickDepartment of Life Science, National Institute of Technology Rourkela, Odisha 769008, India.
Suman JhaDepartment of Life Science, National Institute of Technology Rourkela, Odisha 769008, India. jhas@nitrkl.ac.in.
National Institute of Technology Rourkela · INUniversity of Colorado Anschutz Medical Campus · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles fabricated using medicinal plant extract have great potential in the area of nanomedicine. High surface-to-volume ratio of nanoparticle enhances the local active biomolecules concentration, leading to many fold increase in the medicinal potentials. The silver nanoparticles (AgNPs) fabricated using indigenous medicinal plants of India,

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsBacteriaCell Line, TumorCell SurvivalHumansMetal NanoparticlesParticle SizePlant ExtractsPlants, MedicinalSilverAnti-Bacterial AgentsAntineoplastic AgentsPlant ExtractsSilver

Identifiers

PMID31051451
PMCPMC8676497
OpenAlexW2896961480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.